Security key
89357L303
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 262,134
- Total 13F value
- $262,994
- Share change
- -154,926
- SEC-reported price per share
- $1.00
- Number of holders
- 14
- Value change
- -$46,979
- Number of buys
- 11
- Number of sells
- 4
Report period
Q2 2024
Institutions
14
Top holders
10
RNAZ full security history
Ownership snapshot
Full 13F holder table
Transcode Therapeutics, Inc. SEC filings
Transcode Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of RNAZ - TRANSCODE THERAPEUTICS INC - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Anna Moore
Disclosed value leader
Anna Moore
Comparable rows
0/12
Latest evidence
14 Jun 2024
3/4/5
13F
Highest disclosed value: $791,920
12 rows are not safely comparable across share classes.
Showing 1-6 of 12 holder rows.
Quick read
Anna Moore has the largest disclosed position value at $791.9K.
0 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Anna Moore's linked filing trail.
Disclosed position value
Top 5
Anna Moore
$791.9K
SABBY MANAGEMENT, LLC
$228.7K
Robert Michael Dudley
$91.9K
Virtu Financial LLC
$37K
TWO SIGMA SECURITIES, LLC
$15K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Anna Moore |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$791,920
1,552,785 shares
|
— | 08 Jul 2021 |
| Zdravka Medarova |
3/4/5
Chief Technology Officer, 10%+ Owner
|
—
denominator unverified
|
—
60,000 shares
|
— | 12 Dec 2022 |
| SABBY MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$228,684
334,823 shares
|
— | 31 Mar 2024 |
| Robert Michael Dudley |
3/4/5
Chief Executive Officer, Director
|
—
denominator unverified
|
$91,934
180,262 shares
|
— | 28 Sep 2023 |
| Virtu Financial LLC |
13F
Company
|
—
denominator unverified
|
$37,000
55,329 shares
|
— | 31 Mar 2024 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
—
denominator unverified
|
$15,009
21,975 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
14
Shares
262,134
Rows available
14
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
6
Q2 2024 holders
14
Holder diff
8
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|